• Intimate Care Virginabiotic Formula (Lactobacillus acidophilus La-14®, Lactobacillus rhamnosus HN001™, Lactobacillus reuteri IDCC 3701, Lactobacillus plantarum IDCC 3501)
• Clinically proven to reduce intimate discomfort by 83%² within 6 days, including itching, odor, stinging, abnormal discharge, and dryness.
• Helps maintain vaginal acidity (pH 3.8–4.2), supporting a healthy vaginal microecology.
• Reduces recurrence of intimate discomfort by 50%², targeting common harmful bacteria such as Candida, Escherichia coli, and Gardnerella vaginalis.
• Specially selected French Organic Exocyan™ Cranberry 5000: effective within 6 hours¹, helps reduce bacterial adhesion in the urethra.
• Effectively protects women’s urethral health and reduces recurring discomfort.
• Two capsules daily provide comprehensive intimate care; 64%³ of testers reported no recurrence during the treatment period, helping to soothe stinging, itching, and eliminate odor.
• Vitamin B6 helps relieve premenstrual psychological discomfort (such as irritability) and physical symptoms (such as bloating and fatigue).
• High-efficiency probiotic locking technology, capable of resisting the strong acid environment of the stomach, ensuring that probiotics enter the intestines, maintaining the optimal balance of intestinal health.
• Added prebiotics can promote the growth of probiotics and contribute to intestinal survival and stability, further promoting intestinal health.
• Made with plant-based capsules, suitable for vegetarians.

Exocyan™ Cranberry fruit 25:1 extract, Virginabiotic Blend(Lactobacillus acidophilus La-14®, Lactiplantibacillus plantarum IDCC 3501, Lacticaseibacillus rhamnosus HN001™, Limosilactobacillus reuteri IDCC 3701), white vegetarian capsule (Hypromellose, colo

For daily health maintenance, take 1 capsule daily, with a meal. For fast-acting or recurrence usage, take 2 capsules daily, with a meal. ⁺Kligler B, Cohrssen A. (2008). Am Fam Physician, 78(9):1073-8. ¹Recommended to take 2 capsules (containing more than 36 milligrams of proanthocyanidins, PACs). Howell, Amy B., et al., BMC infectious diseases 10.1 (2010):1-11 ²Cianci A. et al.(2018). J Obstet Gynaecol, 38(5):693-696. ³Nexira Exocyan Clinical study report (2022)